GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (OTCPK:ULIHF) » Definitions » 3-Year FCF Growth Rate

United Laboratories International Holdings (United Laboratories International Holdings) 3-Year FCF Growth Rate : -5.30% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is United Laboratories International Holdings 3-Year FCF Growth Rate?

United Laboratories International Holdings's Free Cash Flow per Share for the six months ended in Dec. 2023 was $0.02.

During the past 12 months, United Laboratories International Holdings's average Free Cash Flow per Share Growth Rate was -21.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -5.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of United Laboratories International Holdings was 47.60% per year. The lowest was -158.60% per year. And the median was -5.30% per year.


Competitive Comparison of United Laboratories International Holdings's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's 3-Year FCF Growth Rate falls into.



United Laboratories International Holdings 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


United Laboratories International Holdings  (OTCPK:ULIHF) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


United Laboratories International Holdings 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (United Laboratories International Holdings) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (United Laboratories International Holdings) Headlines

No Headlines